{
    "clinical_study": {
        "@rank": "124535", 
        "brief_summary": {
            "textblock": "The objectives of this study is to assess the characteristics and frequency of adenovirus\n      conjunctivitis in a population of male and female patients from one year of age who present\n      signs and symptoms of acute conjunctivitis."
        }, 
        "brief_title": "ADenoVirus Initiative Study in Epidemiology in UK", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Viral Conjunctivitis", 
        "condition_browse": {
            "mesh_term": [
                "Conjunctivitis", 
                "Conjunctivitis, Viral", 
                "Conjunctivitis, Inclusion"
            ]
        }, 
        "detailed_description": {
            "textblock": "Epidemiological, prospective, open, multicentric trial in patients suffering from acute\n      conjunctivitis who will undergo a rapid diagnostic test for adenoviral conjunctivitis at the\n      time of their visit to the ophthalmologist office, at the emergency room or during\n      hospitalization. This epidemiological study will include approximately 500 patients in the\n      United Kingdom. The planned duration of the study is one year from the first patient visit\n      to the last patient visit."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or Female patients of at least one year of age presenting acute (for less than 7\n             days) conjunctivitis signs and symptoms.\n\n          -  Patient or / and legal representative (if patient below 18 years of age) must be able\n             to provide oral consent for the collection and treatment of the questionnaire data.\n\n          -  No history of hypersensitivity to corn starch, talcum powder or Dacron (sampling\n             fleece components).\n\n        Exclusion Criteria:\n\n          -  Current use or having received (within the last 7 days) local antiviral therapies\n             such as povidone iodine or ganciclovir, or topical steroids or immunomodulators such\n             as cyclosporine which may interfere with the test result.\n\n          -  Previous enrolment in the present study.\n\n          -  Any direct involvement with the study conduct at site or any family link with study\n             site staff."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "1 Year", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Any female and male patients from one year of age with signs and symptoms of acute\n        conjunctivitis either seen during ophthalmology consultations or who are in the emergency\n        room or hospitalized, can be enrolled in the study"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02112773", 
            "org_study_id": "ADVISE UK"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Adenoviral conjunctivitis diagnosed with AdenoPlus\u2122 Test", 
        "lastchanged_date": "April 10, 2014", 
        "number_of_groups": "1", 
        "official_title": "Epidemiological, Prospective, Multicentric, Open Study To Assess The Characteristics And Frequency Of Adenoviral Conjunctivitis As Diagnosed With The Point Of Care AdenoPlus\u00ae Test In Patients Suffering From Acute Conjunctivitis", 
        "other_outcome": [
            {
                "description": "The number of patients with adenovirus conjunctivitis who visited the ophthalmologist in spring, summer, autumn and winter and their geographic area (e.g. by hospital, by area).", 
                "measure": "Seasonality and geographic repartition observed.", 
                "safety_issue": "No", 
                "time_frame": "During the visit to the ophthalmologist before and just after the AdenoPlus\u00ae test done on the same day (one visit)"
            }, 
            {
                "description": "The percentage of each eye signs and symptoms, the mean duration of the disease for both the patients with positive and negative AdenoPlus\u00ae tests, the number or follow-up visit done and the correlation between the initial diagnosis (before AdenoPlus\u00ae test results) and the final diagnosis (post AdenoPlus\u00ae test results).", 
                "measure": "Clinical profiles of the patients", 
                "safety_issue": "No", 
                "time_frame": "During the visit to the ophthalmologist before and just after the AdenoPlus\u00ae test done on the same day (one visit)"
            }, 
            {
                "description": "Estimation of resource utilized during course of treatment (use of drugs, number of visits done by the patient\u2026), and associated costs (which would be calculated by applying unit costs to resource use).", 
                "measure": "Resource utilization during the treatment and evaluation of the costs", 
                "safety_issue": "No", 
                "time_frame": "On day 1: at least once during the single visit to the ophthalmologist and if any also during the follow-up visit(s)"
            }, 
            {
                "description": "Number of days out of work and/or out of school linked to this disease.", 
                "measure": "Patient/parent absenteeism linked to this disease.", 
                "safety_issue": "No", 
                "time_frame": "On day 1: at least once during the single visit to the ophthalmologist and if any also during the follow-up visit(s)"
            }, 
            {
                "description": "Number of adverse incidents (AIs) and events that are of significant (SEs) reported to Nicox", 
                "measure": "Safety assessment", 
                "safety_issue": "Yes", 
                "time_frame": "On day 1: at least once during the single visit to the ophthalmologist and if any also during the follow-up visit(s)"
            }
        ], 
        "overall_contact": {
            "email": "duquesroix@nicox.com", 
            "last_name": "Brigitte Duquesroix, MD", 
            "phone": "33 (0)4 97 24 53 00"
        }, 
        "overall_official": {
            "affiliation": "Portsmouth Hospitals NHS Trust", 
            "last_name": "Rakesh Jayaswal", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The percentage of patients with adenovirus conjunctivitis documented by a positive AdenoPlus\u00ae test over the tested population of male and female patients who present signs and symptoms of acute conjunctivitis.", 
            "measure": "Frequency of patients with adenovirus conjunctivitis", 
            "safety_issue": "No", 
            "time_frame": "During the visit to the ophthalmologist before and just after the AdenoPlus\u00ae test done on the same day (one visit)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02112773"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "NicOx", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "NicOx", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}